For the quarter ending 2026-03-31, CMRF had $16,768K increase in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Loss on interest rate caps | - | 0 | - | - |
| Return on investment in unconsolidated entities | - | 1,437 | 3,781 | 2,683 |
| Net income (loss) | 43,072 | 29,725 | 30,309 | -7,659 |
| Depreciation and amortization, net | 9,157 | 9,148 | 9,374 | 19,650 |
| Amortization of deferred financing costs | 2,167 | 2,420 | 2,392 | 4,569 |
| Amortization and accretion on deferred loan fees | 3,139 | 2,152 | 1,841 | 3,955 |
| Amortization and accretion of premiums and discounts on credit investments | 1,325 | 1,182 | 1,397 | 2,598 |
| Accretion of interest income on clo subordinated note | -1,012 | -1,022 | -1,013 | -2,037 |
| Capitalized interest income on real estate-related securities and loans held-for-investment | 3,732 | 3,850 | 4,395 | 8,619 |
| Equity-based compensation | 1,223 | 1,294 | 1,298 | 1,970 |
| Straight-line rental income | 884 | -211 | -151 | 3,114 |
| Recovery of uncollectible lease-related receivables | -11 | 5 | -198 | -1,294 |
| Gain on disposition of real estate assets and condominium developments, net | 5,743 | 307 | 2,280 | 5,596 |
| Loss on sale of credit investments, net | 0 | 79 | 70 | -897 |
| Loss (gain) on investment in unconsolidated entities | -971 | 1,437 | 3,781 | 3,922 |
| Unrealized gain on equity securities | 3,317 | 2,071 | 2,458 | 1,190 |
| Impairment of real estate assets | 0 | 2,186 | 0 | 7,674 |
| (decrease) increase in provision for credit losses | -7,123 | -2,616 | 6,445 | 66,978 |
| Write-off of deferred financing costs | 282 | 274 | 0 | - |
| Rents and tenant receivables, net | -67 | -552 | -2,428 | 783 |
| Prepaid expenses and other assets | -2,819 | -285 | 3,136 | -1,093 |
| Accrued interest receivable | -689 | -1,857 | -669 | -1,134 |
| Accrued expenses and accounts payable | -2,599 | -1,636 | -304 | 860 |
| Deferred rental income and other liabilities | -429 | 527 | -1,243 | 1,990 |
| Due to affiliates | 1,338 | -254 | -7 | -758 |
| Net cash provided by operating activities | 32,471 | 33,315 | 34,724 | 67,973 |
| Investment in unconsolidated entities | 24,375 | 619 | 1,600 | 24,319 |
| Return of investment in unconsolidated entities | 47,453 | 14,414 | 4,148 | 41,454 |
| Investment in real estate-related securities and other | - | 22,103 | 4,597 | - |
| Investment in liquid corporate senior loans | 0 | 0 | 0 | 1,251 |
| Investment in real estate assets and capital expenditures | 3,590 | 33,180 | 29,923 | 14,956 |
| Net proceeds from deeds-in-lieu of foreclosure | 0 | 0 | 0 | 1,655 |
| Investment in corporate senior loans | 37,393 | 28,395 | 23,766 | 73,456 |
| Origination and funding of first mortgage loans | 66,758 | 449,492 | 30,874 | 170,418 |
| Origination and exit fees received on first mortgage loans | 1,251 | 5,342 | 465 | 3,906 |
| Principal payments received on loans held-for-investment | 483,840 | 220,296 | 80,208 | 261,508 |
| Principal payments received on real estate-related securities | 513 | 85,990 | 40,039 | 2,747 |
| Proceeds from the repayment on the clo subordinated note | 1,092 | 1,228 | 958 | 3,884 |
| Net proceeds from sale of real estate-related securities | 0 | 14,721 | 17,295 | 43,616 |
| Net proceeds from disposition of real estate assets and condominium developments | 18,554 | 5,478 | 104,439 | 60,729 |
| Proceeds from sale of loans | 0 | 289 | 0 | 4,788 |
| Payment of loan escrow deposits | 27,309 | 1,926 | 0 | - |
| Refund of property escrow deposits | - | 1,926 | 0 | - |
| Net cash provided by (used in) investing activities | 393,278 | -186,031 | 156,792 | 139,887 |
| Redemptions of common stock | 8,227 | 8,243 | 8,325 | 20,486 |
| Distributions to stockholders | 29,770 | 29,659 | 29,539 | 62,095 |
| Proceeds from borrowings | 33,510 | 398,843 | 113,329 | 252,569 |
| Repayments of borrowings | 401,056 | 276,836 | 170,070 | 398,254 |
| Contributions from non-controlling interests | 46 | 207 | 251 | 950 |
| Deferred financing costs paid | 3,484 | 1,529 | 2,937 | 774 |
| Net cash used in financing activities | -408,981 | 82,783 | -97,291 | -228,090 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 16,768 | -69,933 | 94,225 | -20,230 |
| Cash and cash equivalents and restricted cash, beginning of period | 189,272 | 259,205 | 185,210 | - |
| Cash and cash equivalents and restricted cash, end of period | 206,040 | 189,272 | 259,205 | - |